Viewport Meta

IPhone / Mobile Compatible

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

Google Font API

Google Analytics

DNSSEC

Founder and CEO

Mark DePristo

Founder and CSO

Peyton Greenside

Scientific Director, External Programs

Jamie Haddon

Senior Director of Preclinical Development

Jon Wojciak

Director of Translational Research

Ryan Henrici

Operations

Tasha Mathews

Tim Park

Machine Learning Scientist

Aaron Solomon

Scientist, Cell-Free Production

Adam Carr

Engineering

Amado (AJ) Toledo

Vineeta Agarwala

Theresa Tribble

Steven J. Kafka

Robert Chess

Andrew Harrison

Co-Founder and CEO

Co-Founder and CSO

Liz Schwarzbach

Chief Business Officer

Francisco Gimenez

Director Board of Directors

Ed Abrams

Chief Information Officer

San Francisco Bay Area Startups with Female Founders

United States Early Stage Companies (Top 10K)

University of Cambridge Alumni Founded Companies

California Early Stage Companies With More Than 50 Employees

BigHat is a developer of an AI-guided protein therapeutic platform used to integrate antibody characterization lab with machine learning technologies to engineer molecules with more complex functions and better biophysical properties. The company is applying these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.

Section 32 Series B - BigHat Biosciences

Andreessen Horowitz

Series A - BigHat Biosciences

National Institute of Standards and Technology

Grant - BigHat Biosciences

Seed Round - BigHat Biosciences

San Mateo

California

United States

North America

BigHat Biosciences

Lonza's Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADC

Liz Schwarzbach, Chief Business Officer at BigHat Biosciences

BigHat Biosciences' Collaboration with Janssen Biotech – Global Legal Chronicle

BigHat Biosciences’ Collaboration with Janssen Biotech

Tech driven biology and chemistry: Solving science’s hardest problems at scale

BigHat Biosciences Enters Into Strategic Collaboration to Leverage Machine Learning in Antibody Discovery & Design

BigHat Biosciences on LinkedIn: Natalie Alba

ABBV: Analyzing December Profit Potential for the Top 4 ...

A full-stack antibody discovery and engineering platform that integrates synthetic biology-based high-speed wet lab with machine learning technologies to create better antibodies faster.

A custom-built, cloud-native LIMS and operating system that oversees the Milliner platform, controlling instruments, coordinating robots, scheduling tasks, managing data, and training ML models.

Development of therapeutic antibodies for oncology, inflammatory diseases, and immunology, focusing on next-generation formats like camelid and human VHHs, scFvs, multispecifics, and conjugates.

Collaborations with biopharma and biotech companies to tackle complex protein therapeutic design challenges, leveraging BigHat's technology and expertise.

India

Asia

Singapore

Turkey

Europe

Indonesia

BigHat Biosciences is a novel protein therapeutics company and developer of an AI-guided antibody design platform. The company's mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. BigHat's AI-enabled experimental platform integrates a high-speed wet lab with machine learning technologies to speed up the antibody engineering process.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 7, 2024 4:08 AM	355deaee
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 7, 2024 4:08 AM	d730a5b3
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	54485710
crunchbase profile	general	Nov 25, 2024 9:42 AM	e7f62e38
li profile	general
translate crunchbase fundingrounds	general	Nov 25, 2024 1:52 PM	0bdefa67
peers	general
news basic	general	Mar 7, 2024 4:08 AM	6b6e1ff7
bundesanzeiger	filings
financials download nd	financials
private financials	financials

BIGH

COM:BIGHATBIO

BigHat Biosciences